Ajna Lukic

Title: Innovator Spotlight: Ajna Lukic and Her Contributions to Pharmaceutical Chemistry

Introduction

Ajna Lukic, based in Smarje-Sap, Slovenia, is a pioneering inventor recognized for her significant contributions to the field of pharmaceutical chemistry. With one patent to her name, she has demonstrated her innovative capabilities, particularly in the conversion of ascomycin to a more purified form of pimecrolimus. Through her work, she aims to enhance the industrial applicability and cost-effectiveness of this important pharmaceutical compound.

Latest Patents

Ajna Lukic holds a pivotal patent titled "Process to convert technical ascomycin into purified pimecrolimus." This innovative process involves chlorinating crude ascomycin with triphenylphosphine and N-chlorosuccinimide (NCS) to generate crude pimecrolimus. The subsequent purification process utilizes high-pressure liquid chromatography (HPLC) and crystallization techniques, allowing for the efficient removal of homologs without necessitating prior purification of the ascomycin starting material. This advancement has the potential to significantly lower production costs and enhance the commercial viability of pimecrolimus.

Career Highlights

Ajna is currently employed at Meda AB, an esteemed company in the pharmaceutical sector. Her position allows her to work at the intersection of research and practical application, facilitating the development of essential processes that can lead to improved drug formulations. Her career is marked by a commitment to innovation and excellence in the field of pharmaceutical chemistry.

Collaborations

Throughout her career, Ajna Lukic has collaborated with respected professionals in her field, including coworkers Borut Gabriel and Aljaz Kajtna. These collaborations not only amplify her research capabilities but also contribute to a collaborative spirit within the pharmaceutical research community, driving forward the quest for groundbreaking solutions.

Conclusion

Ajna Lukic exemplifies the spirit of innovation in pharmaceutical chemistry through her impactful work on the conversion of ascomycin to purified pimecrolimus. Her contributions have the potential to revolutionize manufacturing processes in the industry, making essential drugs more accessible and affordable. As she continues to develop her expertise and collaborate with fellow researchers, Ajna stands as an inspiring figure in the realm of inventors and innovations.